Question 1

What are the specific eligibility criteria for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to standard options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer clinical trial (NCT04194554). Contact the study team or your healthcare provider for specific answers.

What this study is about